David Zahavi is a PhD candidate at Georgetown University in the Tumor Biology Program. David’s current research focus is identifying tumor cell resistance mechanisms to monoclonal antibody therapy and developing improved immunotherapies for cancer. David is pursuing a career in science policy in order to help guide policymakers in addressing problems faced by translational researchers, challenges in communicating complex scientific information, and issues surrounding emerging technologies. Outside the lab, David enjoys running, trying new restaurants, and going to the movies.